AI Article Synopsis

  • * This study aimed to evaluate the effectiveness of transcutaneous electrical nerve stimulation (TENS) therapy for reducing chronic pain in patients with muscular dysfunction symptoms.
  • * Results showed that while some patients experienced complete pain relief, others did not respond at all, confirming that TENS therapy can be beneficial for muscle relaxation and pain reduction in certain cases.

Article Abstract

Introduction: Patients with craniomandibular disorders suffer from hypertonic, fatigued and painful masticatory muscles.This condition can lead to limitation of mandibular jaw movements. All of these symptoms and signs are included in myofascial pain dysfunction syndrome.Transcutaneous electrical nerve stimulation (TENS) has been used for treatment of these patients.

Objective: The aim of this study was to assess the effect ofTENS therapy on chronic pain reduction in patients with the muscular dysfunction symptom.

Methods: In order to evaluate the effect ofTENS therapy before and after the treatment, Craniomandibular Index (Helkimo) was used. Pain intensity was measured by VAS. Patients had TENS treatment over two-week period. BURST TENS modality was used. Current intensity was individually adjusted.

Results: Two patients did not respond to TENS therapy. Complete pain reduction was recorded in 8 patients, while pain reduction was not significantly different after TENS therapy in 10 patients.

Conclusion: TENS therapy was confirmed as therapeutic procedure in orofacial muscle relaxation and pain reduction.

Download full-text PDF

Source
http://dx.doi.org/10.2298/sarh1404150dDOI Listing

Publication Analysis

Top Keywords

pain reduction
16
tens therapy
12
electrical nerve
8
nerve stimulation
8
tens treatment
8
oftens therapy
8
therapy
6
pain
6
tens
6
reduction
5

Similar Publications

Background: Physicians worldwide face the challenging task of improving patient satisfaction by reducing pain in injured patients. Currently, available therapeutic approaches provide only short-term relief of symptoms without addressing long-term satisfaction. This has led to exploring regenerative treatment options that can deliver better outcomes.

View Article and Find Full Text PDF

Background: Chronic graft-vs-host disease (cGvHD) is a severe immune-mediated complication that affects patients following allogeneic hematopoietic stem cell transplantation (allo-HSCT). Oral manifestations of cGvHD, such as ulcers and mucosal inflammation, significantly impair quality of life and often require long-term treatment. Existing therapies provide limited relief, prompting the exploration of new approaches, including the use of autologous platelet lysate (PL) gel for its regenerative properties.

View Article and Find Full Text PDF

Background: Several health care networks have fully adopted second-generation supraglottic airway (SGA) i-gel. Real-world evidence of enhanced patient safety after such practice change is lacking. We hypothesized that the implementation of i-gel compared to the previous LMA®-Unique™ would be associated with a lower risk of airway-related safety events.

View Article and Find Full Text PDF

Aim: To perform a systematic review to investigate if the use of audio distraction reduces signs of stress and anxiety in paediatric patients undergoing dental treatment.

Materials And Methods: Search was made in electronic databases (MEDLINE, Scopus, Embase, Web of Science, Scielo, BVS, Springer Link, Science Direct, Cochrane Library, and grey literature) until March 11th, 2024. The eligibility criteria were: paediatric patients under dental treatment; use of audio as a distraction method; comparison between groups with and without use of audio distraction; Clinical trials.

View Article and Find Full Text PDF

Erlotinib-induced Perioral Lesions Resembling Scleroderma.

Acta Dermatovenerol Croat

November 2024

Constantin A. Dasanu MD, PhD, Lucy Curci Cancer Center, Eisenhower Health, 39000 Bob Hope Dr, Rancho Mirage, CA 92270 , USA;

Erlotinib, an epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI), is currently used in the therapy of several solid malignancies. This agent has been associated with several dermatological side-effects, the most common being papulo-pustular acneiform rash. Herein we describe a unique skin effect in a patient treated with erlotinib for non-small cell lung cancer.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!